Guardant Health
GH
#1107
Rank
โ‚น2.015 T
Marketcap
โ‚น14,897
Share price
2.35%
Change (1 day)
72.33%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of June 2026 : โ‚น179.81 Billion

According to Guardant Health 's latest financial reports the company's total assets are โ‚น179.81 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚น148.71 B11.63%
2022-12-31โ‚น133.22 B-18.81%
2021-12-31โ‚น164.08 B-1.24%
2020-12-31โ‚น166.14 B142.05%
2019-12-31โ‚น68.63 B67.12%
2018-12-31โ‚น41.07 B87.57%
2017-12-31โ‚น21.89 B176.44%
2016-12-31โ‚น7.92 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Neogen
NEOG
โ‚น310.60 B 72.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚น249.89 B 38.97%๐Ÿ‡บ๐Ÿ‡ธ USA